name: 'gene-panel-design-agent'
description: 'AI-powered design of targeted gene panels for clinical and research applications including cancer diagnostics, pharmacogenomics, and rare disease testing.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
Gene Panel Design Agent
The Gene Panel Design Agent provides AI-driven design of targeted sequencing panels for clinical diagnostics, cancer profiling, pharmacogenomics, and research applications.
When to Use This Skill
- When designing custom gene panels for clinical or research use.
- To optimize panel content for specific disease areas.
- For balancing panel size with diagnostic yield.
- When designing probes for hybrid capture or amplicon approaches.
- To validate panel performance computationally.
Core Capabilities
Gene Selection: Evidence-based gene prioritization for disease areas.
Target Region Definition: Specify exons, introns, UTRs, promoters to include.
Probe Design: In silico probe/primer design for capture or amplicon.
Coverage Prediction: Estimate uniformity and dropout risk.
Validation Planning: Design positive controls and performance metrics.
Cost Optimization: Balance panel size with clinical utility.
Workflow
Input: Disease focus, required genes, platform choice, size constraints.
Gene Prioritization: Rank genes by clinical evidence level.
Region Definition: Define target coordinates.
Probe Design: Generate capture probes or primers.
Coverage Simulation: Predict sequencing performance.
Optimization: Iterate design for uniformity.
Output: Panel BED file, probe sequences, validation plan.
Example Usage
User: "Design a comprehensive solid tumor panel covering actionable mutations and resistance markers."
Agent Action:
python3 Skills/Genomics/Gene_Panel_Design_Agent/panel_designer.py \
--disease solid_tumor \
--gene_sources nccn,civic,oncokb \
--platform hybcap \
--target_size 1.5mb \
--include_fusions true \
--include_cnv_backbone true \
--output panel_design/
Panel Design Considerations
| Factor |
Impact |
Optimization |
| Panel size |
Cost, depth |
Prioritize high-evidence genes |
| GC content |
Coverage uniformity |
Probe design, blockers |
| Repeat regions |
Mapping challenges |
Avoid or boost coverage |
| Homologous regions |
Misalignment |
Unique design, blockers |
| Structural variants |
Detection |
Intronic coverage, breakpoints |
| CNV detection |
Require backbone |
Tiled probes across genome |
Gene Prioritization Sources
| Source |
Content |
Evidence Level |
| OncoKB |
Actionable alterations |
FDA/guideline levels |
| CIViC |
Clinical variants |
Community-curated |
| ClinVar |
Pathogenic variants |
Classification criteria |
| NCCN |
Guideline genes |
Clinical practice |
| COSMIC |
Cancer genes |
Census tier 1/2 |
Panel Types
Comprehensive Cancer Panel (300-700 genes):
- All known cancer drivers
- Actionable mutations
- Resistance markers
- MSI/TMB estimation
Focused Tumor Panel (50-100 genes):
- Most actionable genes
- Cost-effective
- Higher depth possible
Pharmacogenomics Panel:
- CPIC/DPWG genes
- CYP450, HLA, transporters
- Star allele compatible design
Rare Disease Panel:
- Disease-specific genes
- Deep intronic variants
- CNV detection
AI/ML Components
Gene Ranking:
- Literature mining for evidence
- Mutation frequency weighting
- Actionability scoring
Probe Optimization:
- GC content balancing
- Tm normalization
- Off-target minimization
Coverage Prediction:
- ML models from historical data
- GC-coverage relationships
- Dropout prediction
Validation Planning
Performance Metrics:
- Coverage uniformity (CV)
- On-target rate
- Sensitivity by variant type
- Reproducibility
Reference Materials:
- Horizon Discovery cell lines
- SeraCare controls
- Well-characterized samples
- In silico spike-ins
Technical Specifications
| Platform |
Typical Size |
Depth |
CNV Capable |
| Hybrid capture |
1-3 Mb |
500-1000x |
Yes (with backbone) |
| Amplicon |
10-500 kb |
1000-5000x |
Limited |
| Anchored multiplex |
Variable |
Variable |
Fusions |
Prerequisites
- Python 3.10+
- BEDTools for coordinate manipulation
- Probe design algorithms
- Reference genome and annotations
Related Skills
- CRISPR_Design_Agent - For guide design
- Variant_Interpretation - For variant selection
- Tumor_Mutational_Burden_Agent - For TMB panel requirements
Output Files
| File |
Content |
Purpose |
| panel.bed |
Target coordinates |
Sequencing design |
| probes.fa |
Probe sequences |
Manufacturing |
| genes.csv |
Gene list with rationale |
Documentation |
| validation.pdf |
QC plan |
Laboratory setup |
Author
AI Group - Biomedical AI Platform
1---2name: gene-panel-design-agent3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: 'gene-panel-design-agent'20description: 'AI-powered design of targeted gene panels for clinical and research applications including cancer diagnostics, pharmacogenomics, and rare disease testing.'21measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.22allowed-tools:23 - read_file24 - run_shell_command25---262728# Gene Panel Design Agent2930The **Gene Panel Design Agent** provides AI-driven design of targeted sequencing panels for clinical diagnostics, cancer profiling, pharmacogenomics, and research applications.3132## When to Use This Skill3334* When designing custom gene panels for clinical or research use.35* To optimize panel content for specific disease areas.36* For balancing panel size with diagnostic yield.37* When designing probes for hybrid capture or amplicon approaches.38* To validate panel performance computationally.3940## Core Capabilities41421. **Gene Selection**: Evidence-based gene prioritization for disease areas.43442. **Target Region Definition**: Specify exons, introns, UTRs, promoters to include.45463. **Probe Design**: In silico probe/primer design for capture or amplicon.47484. **Coverage Prediction**: Estimate uniformity and dropout risk.49505. **Validation Planning**: Design positive controls and performance metrics.51526. **Cost Optimization**: Balance panel size with clinical utility.5354## Workflow55561. **Input**: Disease focus, required genes, platform choice, size constraints.57582. **Gene Prioritization**: Rank genes by clinical evidence level.59603. **Region Definition**: Define target coordinates.61624. **Probe Design**: Generate capture probes or primers.63645. **Coverage Simulation**: Predict sequencing performance.65666. **Optimization**: Iterate design for uniformity.67687. **Output**: Panel BED file, probe sequences, validation plan.6970## Example Usage7172**User**: "Design a comprehensive solid tumor panel covering actionable mutations and resistance markers."7374**Agent Action**:75```bash76python3 Skills/Genomics/Gene_Panel_Design_Agent/panel_designer.py \77 --disease solid_tumor \78 --gene_sources nccn,civic,oncokb \79 --platform hybcap \80 --target_size 1.5mb \81 --include_fusions true \82 --include_cnv_backbone true \83 --output panel_design/84```8586## Panel Design Considerations8788| Factor | Impact | Optimization |89|--------|--------|--------------|90| Panel size | Cost, depth | Prioritize high-evidence genes |91| GC content | Coverage uniformity | Probe design, blockers |92| Repeat regions | Mapping challenges | Avoid or boost coverage |93| Homologous regions | Misalignment | Unique design, blockers |94| Structural variants | Detection | Intronic coverage, breakpoints |95| CNV detection | Require backbone | Tiled probes across genome |9697## Gene Prioritization Sources9899| Source | Content | Evidence Level |100|--------|---------|----------------|101| OncoKB | Actionable alterations | FDA/guideline levels |102| CIViC | Clinical variants | Community-curated |103| ClinVar | Pathogenic variants | Classification criteria |104| NCCN | Guideline genes | Clinical practice |105| COSMIC | Cancer genes | Census tier 1/2 |106107## Panel Types108109**Comprehensive Cancer Panel** (300-700 genes):110- All known cancer drivers111- Actionable mutations112- Resistance markers113- MSI/TMB estimation114115**Focused Tumor Panel** (50-100 genes):116- Most actionable genes117- Cost-effective118- Higher depth possible119120**Pharmacogenomics Panel**:121- CPIC/DPWG genes122- CYP450, HLA, transporters123- Star allele compatible design124125**Rare Disease Panel**:126- Disease-specific genes127- Deep intronic variants128- CNV detection129130## AI/ML Components131132**Gene Ranking**:133- Literature mining for evidence134- Mutation frequency weighting135- Actionability scoring136137**Probe Optimization**:138- GC content balancing139- Tm normalization140- Off-target minimization141142**Coverage Prediction**:143- ML models from historical data144- GC-coverage relationships145- Dropout prediction146147## Validation Planning148149**Performance Metrics**:150- Coverage uniformity (CV)151- On-target rate152- Sensitivity by variant type153- Reproducibility154155**Reference Materials**:156- Horizon Discovery cell lines157- SeraCare controls158- Well-characterized samples159- In silico spike-ins160161## Technical Specifications162163| Platform | Typical Size | Depth | CNV Capable |164|----------|--------------|-------|-------------|165| Hybrid capture | 1-3 Mb | 500-1000x | Yes (with backbone) |166| Amplicon | 10-500 kb | 1000-5000x | Limited |167| Anchored multiplex | Variable | Variable | Fusions |168169## Prerequisites170171* Python 3.10+172* BEDTools for coordinate manipulation173* Probe design algorithms174* Reference genome and annotations175176## Related Skills177178* CRISPR_Design_Agent - For guide design179* Variant_Interpretation - For variant selection180* Tumor_Mutational_Burden_Agent - For TMB panel requirements181182## Output Files183184| File | Content | Purpose |185|------|---------|---------|186| panel.bed | Target coordinates | Sequencing design |187| probes.fa | Probe sequences | Manufacturing |188| genes.csv | Gene list with rationale | Documentation |189| validation.pdf | QC plan | Laboratory setup |190191## Author192193AI Group - Biomedical AI Platform194195196<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->